Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Loxenatide

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Company n/r · Phase 2/3 · Completed · Enrollment 30

NCT05172999

ArmPopulationDoseWeeksEstimandWeight change
LNG-IUSObesity or overweightn/rn/rn/rn/r
LOX+LNG-IUSObesity or overweightn/rn/rn/rn/r